ArticleBioengineering (Basel, Switzerland)2026
AI-Driven Three-Dimensional Reconstruction of Fetal Cardiovascular Pathways from Ultrasound Sweep Videos for Congenital Heart Disease Screening.
Naoaki Harada, Masaaki Komatsu, Naoki Teraya, Shohei Wakisaka, Katsuji Takeda, Takashi Natsume, Tomonori Taniguchi, Nobuji Kouno, Satoshi Takahashi, Ken Asada and 7 more
Abstract read
In one paragraphArticle in Bioengineering (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
17 authors.
Naoaki HaradaDepartment of NCC Cancer Science, Biomedical Science and Engineering Track, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8510, Japan.
Masaaki KomatsuDivision of Medical AI Research and Development, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.ORCID 0000-0003-0421-8085 Naoki TerayaDepartment of Obstetrics and Gynecology, Showa Medical University School of Medicine, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo 142-8666, Japan.ORCID 0009-0005-1296-8152 Shohei WakisakaDivision of Medical AI Research and Development, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.
Katsuji TakedaDepartment of NCC Cancer Science, Biomedical Science and Engineering Track, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8510, Japan.ORCID 0009-0006-8053-8098 Takashi NatsumeDivision of Medical AI Research and Development, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.ORCID 0000-0002-8240-0264 Tomonori TaniguchiDivision of Medical AI Research and Development, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.ORCID 0009-0007-4428-0779 Nobuji KounoDivision of Medical AI Research and Development, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.
Satoshi TakahashiDivision of Medical AI Research and Development, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.
Ken AsadaDivision of Medical AI Research and Development, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.ORCID 0000-0003-0548-4449 Syuzo KanekoDivision of Medical AI Research and Development, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.ORCID 0000-0003-4558-9800 Mayumi KanekoDepartment of Obstetrics and Gynecology, Showa Medical University School of Medicine, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo 142-8666, Japan.ORCID 0000-0002-0613-446X Reina KomatsuDepartment of Obstetrics and Gynecology, Showa Medical University School of Medicine, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo 142-8666, Japan.ORCID 0009-0008-7681-9051 Kazuki IwamotoDigital Health Platform Development Office, Healthcare Business Unit, Fujitsu Japan Ltd., 1-5 Omiya-cho, Saiwai-ku, Kawasaki 212-0014, Japan.
Ryu MatsuokaDepartment of Obstetrics and Gynecology, Showa Medical University School of Medicine, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo 142-8666, Japan.ORCID 0000-0003-0354-4145 Akihiko SekizawaDepartment of Obstetrics and Gynecology, Showa Medical University School of Medicine, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo 142-8666, Japan.ORCID 0000-0003-2249-1333 Ryuji HamamotoDepartment of NCC Cancer Science, Biomedical Science and Engineering Track, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8510, Japan.ORCID 0000-0002-2632-1334 Funding
Cabinet Office BRIDGEJapan Society for the Promotion of Science JP21K09456Japan Society for the Promotion of Science JP24K12634Japan Society for the Promotion of Science JP25K15973
6 · The paper itselfAbstract
Fetal cardiac ultrasound screening is vital for the prenatal diagnosis of congenital heart disease (CHD). However, understanding complex cardiovascular structures and continuity from two-dimensional (2D) ultrasound images remains challenging. Therefore, this study developed and evaluated an artificial intelligence (AI)-based three-dimensional (3D) visualization approach that reconstructs fetal cardiovascular structures from 2D ultrasound sweep video. To this end, information from the adjacent frames was used. Instead of interpreting each ultrasound frame independently, this method incorporates neighboring frames, enabling the continuous visualization of the right- and left-sided functional circulatory pathways. Our method achieved a mean Dice coefficient of 0.785 on an independent test dataset, demonstrating that the adjacent frame information can provide stable 3D segmentation. Diffusion-based anatomical plausibility analysis trained exclusively on normal anatomies showed exploratory discrimination between normal fetuses and fetuses with CHD (AUC, 0.861; 95% CI, 0.695-0.980). In a clinical comparison study involving 12 obstetricians, the introduction of this AI-driven 3D cardiovascular visualization slightly improved the screening accuracy from 0.779 to 0.808 and significantly improved the confidence-weighted accuracy score (
Indexed as
artificial intelligencecardiovascular structurescontinuityfetal cardiac ultrasound screeningthree-dimensional visualization
Identifiers
PMID42791857
PMCPMC13603691
What OpenQuestion holds
Textmetadata
Read underepoch 390